Mercer Global Advisors
IDXX icon

Mercer Global Advisors’s Idexx Laboratories IDXX Stock Holding History

Mercer Global Advisors’s Portfolio IDXX Stock Details IDXX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$5.27M Buy
9,386
+2,040
+28% +$1.31M 0.01% 736
2025
Q4 		$4.97M Buy
7,346
+759
+12% +$517K 0.01% 722
2025
Q3 		$4.21M Buy
6,587
+1,690
+35% +$1.03M 0.01% 739
2025
Q2 		$2.63M Sell
4,897
-191
-4% -$91.3K 0.01% 776
2025
Q1 		$2.14M Buy
5,088
+421
+9% +$183K ﹤0.01% 818
2024
Q4 		$1.93M Buy
4,667
+321
+7% +$141K ﹤0.01% 840
2024
Q3 		$2.15M Buy
4,346
+51
+1% +$24.8K 0.01% 763
2024
Q2 		$2.04M Buy
4,295
+176
+4% +$88.4K 0.01% 718
2024
Q1 		$2.23M Buy
4,119
+422
+11% +$231K 0.01% 696
2023
Q4 		$2.05M Sell
3,697
-572
-13% -$269K 0.01% 736
2023
Q3 		$1.87M Sell
4,269
-1,005
-19% -$501K 0.01% 732
2023
Q2 		$2.65M Buy
5,274
+181
+4% +$86.7K 0.01% 643
2023
Q1 		$2.55M Buy
5,093
+331
+7% +$158K 0.01% 618
2022
Q4 		$1.94M Buy
4,762
+2,912
+157% +$1.13M 0.01% 692
2022
Q3 		$603K Buy
1,850
+106
+6% +$38.9K ﹤0.01% 1049
2022
Q2 		$611K Buy
1,744
+197
+13% +$80.3K ﹤0.01% 1053
2022
Q1 		$846K Sell
1,547
-176
-10% -$92.6K 0.01% 962
2021
Q4 		$1.14M Buy
1,723
+359
+26% +$225K 0.01% 826
2021
Q3 		$848K Sell
1,364
-16
-1% -$10.8K 0.01% 937
2021
Q2 		$872K Buy
1,380
+329
+31% +$182K 0.01% 905
2021
Q1 		$514K Buy
1,051
+40
+4% +$20K ﹤0.01% 1068
2020
Q4 		$505K Buy
1,011
+229
+29% +$102K 0.01% 854
2020
Q3 		$307K Sell
782
-14
-2% -$5.18K ﹤0.01% 954
2020
Q2 		$263K Sell
796
-374
-32% -$108K ﹤0.01% 895
2020
Q1 		$283K Buy
1,170
+369
+46% +$96.3K 0.01% 830
2019
Q4 		$209K Sell
801
-56
-7% -$14.8K ﹤0.01% 1069
2019
Q3 		$233K Buy
857
+81
+10% +$22.5K 0.01% 986
2019
Q2 		$214K Buy
+776
New +$191K 0.01% 1028

Other funds holding IDXX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $33.1B AUM 11.16% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Fundsmith LLP
Fundsmith LLP London, United Kingdom $12.8B AUM 6.9% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Mercer Global Advisors's IDXX Position: Q1 2026 in Review

Mercer Global Advisors increased its Idexx Laboratories (IDXX) stake by 28% in Q1 2026, buying an estimated $1.31M and bringing the position to 9,386 shares worth $5.27M. The position accounts for 0.01% of the portfolio, ranked #736.

Mercer Global Advisors first reported a position in IDXX in Q2 2019 and has held it in 28 quarters since. 1,311 funds tracked by Wall St. Rank hold IDXX as of Q1 2026.

  • Mercer Global Advisors held 9,386 shares of Idexx Laboratories worth $5.27M as of Q1 2026.
  • Mercer Global Advisors bought 2,040 Idexx Laboratories shares in Q1 2026, an estimated $1.31M.
  • Idexx Laboratories made up 0.01% of Mercer Global Advisors's portfolio in Q1 2026, its #736 holding.
  • Mercer Global Advisors first reported a position in Idexx Laboratories in Q2 2019 and has held it in 28 quarters since.
  • 1,311 funds tracked by Wall St. Rank held Idexx Laboratories as of Q1 2026.

Based on Mercer Global Advisors's 13F filing for Q1 2026, filed 15 May 2026.